CRISPR Therapeutics
CRSP
#3165
Rank
โ‚ฌ3.44 B
Marketcap
40,12ย โ‚ฌ
Share price
-1.21%
Change (1 day)
-45.90%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -โ‚ฌ0.34 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are โ‚ฌ35 Million. a decrease over its 2023 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.34 Billion140.62%
2023 -โ‚ฌ0.14 Billion-76.83%
2022 -โ‚ฌ0.61 Billion-271.4%
2021 โ‚ฌ0.35 B-209.04%
2020 -โ‚ฌ0.33 Billion-617.12%
2019 โ‚ฌ62.34 M-140.93%
2018 -โ‚ฌ0.16 Billion146.86%
2017 -โ‚ฌ61.7 Million193.19%
2016 -โ‚ฌ21.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.14 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA